Hospira Vincristine Sulphate 5 mg/5 mL Injection vial (preserved)

Држава: Аустралија

Језик: Енглески

Извор: Department of Health (Therapeutic Goods Administration)

Активни састојак:

vincristine sulfate, Quantity: 1 mg/mL

Доступно од:

Hospira Australia Pty Ltd

INN (Међународно име):

Vincristine sulfate

Фармацеутски облик:

Injection, solution

Састав:

Excipient Ingredients: benzyl alcohol; mannitol; water for injections

Пут администрације:

Intravenous

Јединице у пакету:

5 x 5 mL pack

Класа:

Medicine Listed (Export Only)

Тип рецептора:

(S1) This Schedule is intentionally blank

Терапеутске индикације:

Vincristine Sulphate Injection is used in the treatment of cancers of the blood (eg. leukaemia or lymphomas), breast, head and neck or lung. It may be used to treat multiple myeloma (a cancer of plasma cells) and it may also be used in the treatment of some cancers in children. It may be used in a blood disorder known as idiopathic thrombocytopenic purpura (ITP) after other treatments have not been successful. Vincristine Sulphate Injection may be given alone or in combination with other anti-cancer medicines.

Резиме производа:

Visual Identification: A clear colourless solution; Container Type: Vial; Container Material: Glass Type I Clear; Container Life Time: 18 Months; Container Temperature: Store at 2 to 8 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Статус ауторизације:

Licence status A

Датум одобрења:

2011-11-02